{
    "nct_id": "NCT03422731",
    "official_title": "Multi-Modality Imaging and Correlative Studies in Patients With Leukemia",
    "inclusion_criteria": "* Cohort TMLI+FLT: AML patients eligible for and enrolling on COH 14012 or IRB 17505 that agree to participate in optional FLT PET imaging\n\n  * Note: patients enrolling on IRB 19518 cannot enroll onto this cohort, but they may enroll on Cohort TMLI (below)\n* Cohort TMLI: AML or ALL patients eligible for and enrolling on COH 14012, IRB 17505 or IRB 19518\n* Cohort TBI: First or second remission AML or ALL patients that will receive TBI (13.2 Gy) plus chemotherapy (etoposide [VP16] 60 mg/kg or cyclophosphamide [Cy] 60 mg/kg for two days) as part of their standard of care\n* Cohort TBI: Documented written informed consent of participant\n* Cohort TBI: Age >= 18 to =< 60 years\n* Cohort TBI: Patients who have not received a prior transplant\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}